CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Conjunctivitis - infective - Management
Topical fusidic acid
- Topical fusidic acid is active against Gram-positive bacteria, especially Staphylococcus aureus, and acquired resistance within Gram-positive species is low.
- Administration of fusidic acid is required only twice a day, which may be of benefit for young children or elderly people who require assistance in applying eye drops.
- If symptoms resolve within the first 5 days of treatment, continue fusidic acid for 48 hours afterwards.
[ABPI Medicines Compendium, 2001; BNF 54, 2007]
© NHS Institute for Innovation and Improvement